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Introduction: The current initial education of pharmacists is changing from a four-year course followed by a
pre-registration year to a 5-year integrated course. A change like this has not previously occurred in the UK,
but Canada and Ireland have previously made similar changes and research was conducted. This means there
is no data concerning students' opinions about  the changes in the UK, especially at this time, where the
changes are recently announced. Therefore, it was important to try to gain an understanding of what these
opinions are.  
Aim: The aim of this study was to identify students' opinions and concerns with the proposed changes and
whether there is a pattern based on year of study within the group. 
Rational and method: Following ethical approval, a survey was developed and distributed amongst the
current MPharm students at the University of Wolverhampton using an online survey. This included both
quantitative and qualitive questions. 
Results: What was found was a clear lack of understanding and confusion amongst the cohort around
use ofwhat these changes mean in the long term for the profession but also for students on an
individual level. Also found was that many students believe the current curriculum doesn’t provide
students with enough clinical experience to be able to become independent prescribers, despite the
fact many of them intend to become independent prescribers and would be more likely to become
pharmacists had it been in place. 
Conclusion: This study identifies  a desire and a need to change the curriculum, but also a lack of
communication to students which could be addressed. 
Introduction          
Currently, in the UK, becoming a registered pharmacist
takes a minimum of 5 years. Four of those years are
spent at university obtaining a Master of Pharmacy
(MPharm) degree on an accredited course, and one-
year training in practice before sitting a final exam
(GPhC, 2020). However, this is set to change: in a joint
letter from the Chief Pharmaceutical Officers and UK
Pharmacy Regulators in July 2020, it was announced
that discussions by the General Pharmaceutical
Council (GPhC) had identified a need for change in the
pharmacy curriculum to reflect the rapidly evolving
roles pharmacists play in practice. This letter
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referenced the importance of a “continuum” of five
years of education and training (Rudkin et al., 2020).
This has been echoed in a joint letter on behalf of
Alan Ryan, Director of National Transformational
Programs, Health Education England and Richard
Cattell, Deputy Chief Pharmaceutical Officer, NHS
England and NHS improvement (2020), which presents
a similar need for the reform of pharmacy education.
It speaks again of the new services that pharmacists
are required to provide, and the additional training
that is required. It points to the initial education and
training currently in place, not being sufficient to
provide these services. This letter also states that the
Covid-19 pandemic and its effects on the current pre-
registration pharmacists provides an opportunity to
accelerate this reform. 
This was supported by Health Education England
who released a review of the advancing pharmacy
education and training, addressing the need for
equipping pharmacists with appropriate clinical
experience in a range of areas, to better sustain the
NHS. This document outlined several principles
that the foundation year would build on, including
increased experiential learning, alignment with a
national curriculum and it would be appropriately and
sustainably funded at a range of levels (HEE, 2019). The
proposed reform, while not finalized, is to replace
the current pre-registration year with a one-year
foundation program to provide the 5th year of
education and training. From as early as summer 2021
this change is being introduced (HEE, 2019). At the
time of writing, these plans are not final and the
ambiguity regarding the funding has been noted by
the Pharmacy Schools Council who have raised
concerns about universities having to pay for the extra
expenses (Andalo, 2019) and contribute to learning in
practice places. Other issues include the students
losing the pre-registration salary while paying fees
for another year at university (Burns, 2019). 
Other countries have used a similar system to the
current one used in the UK such as Australia (Marriot
et al., 2008), New Zealand (Careers,govt.nz, 2020),
Canada (CPhA, 2011) and Ireland (Strawbridge et al.,
2019). There have been similar changes already made
in  Canada and the Republic of Ireland, who reformed
the curriculum as can be seen in table 1 below. 
A PharmD is the clinical university degree program a
pharmacist must complete in America. The Canadian
programme closely mirrors the American; two years,
undergraduate coursework, followed by a four-year
professional degree program (Knoer, Eck and Lucas,
2016). 
The changes proposed in the UK have a stark
difference from the changes made in Canada and
Ireland; the UK changes are aiming to provide future
students with the ability to independently prescribe
upon graduation (Rudkin and Patterson, 2020).
Currently in order for a pharmacist to become an
independent prescriber (IP) they must have been
registered and practising in a patient facing role for a
minimum of two years (GPhC, 2021). The changes to
the curriculum may allow pharmacists to become IPs
faster, and in a similar way to how nurses can become
prescribers. Previously, practising nurses needed to
have two or three years of experience to become a
prescriber, this has already changed in a similar way
to the proposed pharmacy changes. 
The Nursing and Midwifery Council (2021) state that,
rather than having to have a set number of years'




Bachelor's degree comprised of 4 years
undergraduate education followed by one-
year pre-pharmacy education (CPhA, 2011).
Four-year bachelor's degree followed by a
pre-registration year (Strawbridge et al.,
2019)
New curriculum
Doctor of pharmacy degree consisting of
2 years of pre-pharmacy undergraduate
education followed by four years of
pharmacy education (CPhA, 2011).
Integrated 5-year Master of Pharmacy
program (PSI, 2020)
Table 1: Comparison of the changes in curriculum between Canada and Ireland
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prove they are capable of safe and effective practice
at a level of proficiency appropriate to the programme
undertaken, and the intended area of prescribing
practice. This could be through CPD, training modules
and relevant experience. 
Both nurses and pharmacists can only prescribe
within an area of expertise so while nurses could
possibly take only four years of education and training
to begin a prescribing course, current pharmacists
must undergo at least seven. This is a large difference,
and the pharmacy course is currently purely time
dependent, whereas the new nursing standards are
down to evidence of competence. This could be a
model that the pharmacy curriculum may follow,
although this has not been confirmed. 
Examining the changes made to the Canadian
curriculum as outlined by the CPhA (2011), they
mandate a large increase in the number of practice
hours that students must undertake throughout
their course,  provide a much greater emphasis on
experiential learning. This is designed to better tailor
the care pharmacists provide to the needs of the
Canadian healthcare system. The reasoning for the
changes is similar to the reasoning for the proposed
changes in the UK. The practice hours take place
over several placements throughout the course, and
each placement must be approved by a preceptor.
They suggest that by being passed by numerous
preceptors they are more likely to have a passing
grade than if they were passed by a single preceptor.
This is something that the current system in the UK
mostly lacks as a large majority of pre-registration
places are in a single setting with a single tutor
(Mulherin, Legal and Ijaz, 2016). 
Ireland changed their requirements for pharmacist
registration from the four-year degree preceding a
pre-registration year, following concerns over the
pre-registration year having inadequate assessments,
lacking clear educational objectives and poor central
quality control. It was replaced by the National
Pharmacy Internship Program (NPIP). This was
designed to ensure new pharmacists would provide
services safely, professionally and effectively and
develop their knowledge and skills in a practice
environment with participants awarded a master's
degree (Strawbridge et al., 2019). Their aim was to
create a new integrated five-year MPharm program
and since September 2015, all new students starting
a pharmacist qualification in Ireland have been
undertaking a Master's degree programme while the
NPIP qualification concluded at the end of the
2018/2019 academic year (PSI, 2020). For some Irish
students this was not a welcome change, with over
500 students from 3 schools of pharmacy protesting
against the new degree (Paul, 2019). The main cause
for protest was due to the salary for completing a
pre-registration year being removed while the
additional fees for completing a Master’s degree had
been added on with fees, at the time, for the 5th year
being between €7500 and €8500 depending upon the
school of pharmacy (USI and PSA, 2019).
As the response in Ireland was not all positive, it could
be expected that similar reactions may occur in the
UK. Whilst it is a different country and a different
cohort of students there is the ambiguity around
funding that is cause for concern. There has been an
announcement to say that current MPharm students
will not have to pay additional fees and are still
going to be employed for the 5th year, but there is
still no clarification on where future students will
stand in regard to funding. It also remains the case that
a degree will still be awarded after 4 years (Rudkin and
Patterson, 2020). It would be interesting to see how
opinions differ between years of study and if this poses
more of a concern to newer students. 
From June 2021, there will also be a common
registration assessment over the four countries in the
United Kingdom aiming to create a more uniform set
of standards that all pre-registration pharmacists
must pass regardless of where in the UK they are
from. This would improve the quality control of the
assessment, which was an issue that contributed to
Ireland’s change of the curriculum (GPhC, 2019).
Despite the adjustments in Canada’s curriculum to
more closely resemble America’s, and the changes to
Ireland’s curriculum, a recent study from Australia
(Pharmacy Board of Australia, 2020) found that while
feedback raised concerns over whether there were
inconsistencies in the way their curriculum was run, a
majority of interns and preceptors agreed that the
internship year provided them with the necessary
skills and knowledge to practice as competent and
independent pharmacists. 
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Considering this curriculum more closely resembles
the current UK curriculum, this could mean that many
pre-registration students and their tutors are satisfied
with the level of experience and competency gained
during this year. Despite the apparent satisfaction with
the intern year, this report also found interns find
balancing full-time work and full-time study stressful,
this issue may not be as prominent where the practice
experience is gained during placements split over the
final years rather than in one year as is currently the
case in Ireland.
Methods and Design        
While the main question being asked was broad - what
opinions do students have? - this needed to be derived
from several questions. Crucially, do the students
perceive this change as positive, negative or would it
make very little difference? Did the opinions differ
between the years of study depending on how much
they felt they might be affected by these changes?
How will it affect future pharmacists? Will it affect
potential students' likelihood to select this degree?
Would students have been more or less likely to pick
the course if the proposed changes had been in place
when they were choosing their degree?   
Aim
The aim of this study was to develop an understanding
of pharmacy students' opinions on the proposed
changes to merge the pharmacy curriculum and the
pre-registration year and its impacts on those
undertaking the course. 
Figure 1: Responses to rating questions
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Methods and Design 
This study was survey-based using closed and open
questions. The questions were developed after a literature
review of grey documents (reports or position statements)
and primary literature to understand the reasons for the
programme review and proposed changes. 
The Online Survey© builder, under university licence,
was used to develop the online survey including
the participants’ information sheet, and a link was
generated and distributed via public announcement
using the MPharm programme online learning platform
CANVAS™ amongst current pharmacy students, from
the first to the final year, inviting them to participate.
The only inclusion criterion was that the participants
were current students on the MPharm course. The main
obstacle to gathering data of a survey-based project is
that there are no in person events for the MPharm
course due to Covid-19 pandemic. 
The data were collected over November and December
of 2020. The results from this survey were analysed
and reported to illustrate a picture of the student's
views. The data collected from the survey was collated
into a Microsoft® Excel™ spreadsheet for analysis. The
responses to each question were grouped by year to
determine themes and how opinions differ across years. 
The qualitative data was thematically analysed to
facilitate comparisons between years.
Results        
Out of 350 students enrolled in the MPharm
programme, only 43 (12%) students participated.
The low response reflects that, owing to the Covid-19
pandemic lockdown preventing other types of
projects from proceeding, many more students
than usual were undertaking survey-type research
contemporaneously. There were 6 (14.3%) participants
from first year, 5 (11.9%) participants from second
year, 12 (28.6%) participants from third year and
19 (45.2%) participants from fourth year. 
Students were asked if they had heard of the
upcoming GPhC proposed changes to the MPharm
and pre-registration year; 38 (90.5%) participants
responded yes. Of those responding no, 3 were in year
1 and one was in year 3 of their studies.
The survey next asked participants to respond to five
questions using a scale from 1 (very detrimental) to 10
(very beneficial), the responses can be seen in figure 1 (all
participants) and figure 2 by year in the MPharm course.
Analysing the results on a year-by-year basis, it was
found that students’ main concern, was the loss of one
year pay whilst in addition gaining an extra year of fees
(Question 7). All students seemed to welcome the
concept of improving the clinical experience (question
3) and agreed to the changes would impact the current
student cohort (Question 6). 
Figure 2: Mean scores by year in the MPharm course
Q3: Compared to the current curriculum, how will the changes affect students clinical experience?
Q4: Compared to the current curriculum, how will the changes affect student's financial situation?
Q5: Compared to the current curriculum, how will the changes affect students work/life balance?
Q6: Compared to the current curriculum, how will the changes affect current students?
Q7: Compared to the current curriculum, how will the changes affect future students finance (their earning during the pre-
registration year and finance with additional year fees?
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When students were asked about their thoughts about
being able to independently prescribe as soon as they
graduated and registered, 26 (61.9%) of the participants
responded positively (66% of first year, 75% of second
years, 73% of third years and 53% of fourth years). 
Asked to justify their choice; the responses can be seen
in table 2. Only 34 students left a written response.
Key themes identified across the years were that
students welcomed becoming IPs, providing that
the course is adjusted appropriately to prepare them
to do that. However, they also clearly expressed their
perception that the current curriculum does not
provide them with enough experience to facilitate this,
and the belief that not every pharmacist will need, or
want, to become an IP.
Asked if they would make the same decision again to
join an MPharm course if they had previously known






“It’s an important aspect in Pharmacy to be
able to prescribe”
“Yes, because students after registration
must be able to demonstrate that they have
the sufficient clinical knowledge and
experience in order to diagnose and
confidently prescribe the appropriate
medications according to NICE guidelines
etc.”
“If the foundation year is going to be more
clinical based, then surly the students will
have knowledge skills to be able to prescribe”
“Because I believe after registering you would
have a lot of knowledge of not only medicines
but also conditions so it only makes sense to
me that students should be allowed to
independently prescribe after registering”
“I believe that 5 years in pharmacy school is
enough to be a prescriber, given the clinical
courses are adjusted accordingly”
“I think that during the degree we are taught
many drugs, we do dispensing and we are
aware of side effects, monitoring etc.”
“The MPharm course should be changed so more
clinical and face to face experience to enable
students to be comfortable around patients”
“As community pharmacists are becoming less
desirable it is important to ensure that they have
as many skills and knowledge as possible”
“Because by the time we graduate we should be
able to diagnose and know what drug will be the


























“The range of prescribing is so vast, many
students do not know which sector or even
interest they would choose upon
registration. For example, somebody may
attain a pre-registration placement in
community, but go on to a role in Aseptic.
So, their initial prescribing experience may
not be relevant for following years”
“I think they shouldn't because mistakes are
easy to make and a mistake early in their
career could lead to them never being able
to prescribe again this is unfair as they are
new and are expected to make mistakes”
“Because students are newly qualified,
they should experience working as a
pharmacist in general before being able to
prescribe as prescribing is a step beyond
what they've learnt so far and should take
time before this happens. And so, the
separate prescriber course should be kept
when pharmacists want to become
prescribers in future”
“I think a certain degree of experience
would be necessary for them to prescribe”
“I think students should be familiar with
independent prescribing and choose to
whether go into independent prescribing
or not”
Table 2: Qualitative responses when asked if students should be allowed 


































“Yes, they have a sufficient amount of
knowledge”
“As you are aware of the signs and symptoms of
general problems that occur with people”
“I think if the student has undergone training as
part of their foundation programme to become
an IP then once they are registered they should
be able to practice this”
“A pharmacist is a specialist in medication and
understand how a medicine works, why and
any side effects that could occur. There is a less
likely chance of a patient being given the wrong
medication and optimisation could occur”
“It is an integral part of the job”
“They are qualified enough to write a
prescription, but should be trained first as 
pre-reg for example”
“It is very valuable since the role of a
pharmacist is evolving to include more
responsibilities”
“Fourth years will have fresh clinical
knowledge and as long as the foundation
year presents with different scenarios that
will mimic pre-registration, I think I will 
prove beneficial”
“I feel that while the knowledge is still fresh
and we still learning would be much better
now then later”
“Provided the changes implemented are
sufficient to equip students with the right
clinical and social skills to become
prescribers, I think becoming prescribers is
appropriate”
“As long as they receive the appropriate
training I don't see why not. As current
pharmacists have to do an additional course
for this anyway, so I think it will be beneficial







“I think a certain level of experience is required
that isn’t necessarily achieved until after fully
qualifying and working as a pharmacist”
“Extensive experience would be required
before prescribing and the current MPharm
degree doesn't offer much placements”
“Experience is must before prescribing independently
because they are still learning and under training.
Therefore, I do not think it is better option”
“As much as I would like to say yes, my honest
answer is no. I believe after registering a
student still needs more experience,
especially those students who haven't had a
long-extended experience within the
pharmacy environment whether that is via
community or hospital, during their university
years, as these students have only gathered
experience truly via their pre reg. 2 years is
enough including pre reg, in order to be able
to independently prescribe in my opinion”
“Need more experience in dealing with
medicines”
“I feel like they don't have much experience”
“unless there isn't prescribing teaching within
the course then students will not be able to
prescribe straight away”
“I believe some experience is vital before being
able to prescribe. There are many things that can
only be learnt through practise and so teaching
straight away and then giving that prescribing
right without the students having had any actual
long-term experience is may not benefit them in
being able to correctly and effectively prescribe”
“Pharmacy students receive nowhere near
enough clinical training while at university.










Table 2 (Continued): Qualitative responses when asked if students should be allowed 








“We will likely by the final year of students who do not have
an IP course included within the degree. This could hinder
job opportunities where employers may favour those with
an IP qualification”
“Getting placements, more studying”
“In terms of new pharmacists competing for a job with me
they could have an advantage”
“if it not rolled out for the current students I will not the
beneficiary of the curriculum change”
“Finically as current per reg year students are
employed/paid. Better chance of employment if IP trained
and will not to have to wait 2 more years to become IP”
“Being a prescriber before you've yet to have certain
experiences working in pharmacy might be a bit
overwhelming”
“Though I'm not a part of the year group that it'll take effect,
the fact that this is coming into place makes me want to get
addition qualifications i.e., do additional studies to become
an IP after having graduated as it shows that pharmacists
are becoming more value”
“It changes my knowledge and what I understood about
the current curriculum. Its more confusing”
“Job prospects. Finding a Pre Reg placement more difficult”
“I may have to follow previous rules, where experience is
required to become a prescriber and newer students would
not need to be experienced at all”
“Because I feel like I’m more than a pharmacist, if I am able
to prescribe it’s like I can apply my knowledge to
something”
“As it would cause changes for us when the course does
change”
“Foundation year will be more of a mix between learning
and working compared to pre-reg year which was mostly































“I intend to do the course after
anyway”
“My aims are to complete the
MPharm and registration,
obtain experience within
clinical Pharmacy and then find
a DMP and do the non-medical
independent prescribes course”
“I wanted to become an IP
anyway so this works in my
favour”
“I fail to see how it would affect
myself currently or in the future
as I would like to do an
independent prescribing course
in the future, however if it was
implemented in the current
MPharm course then it would
save me time I guess”
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responded ‘yes.’ Only 17% of first years responded yes,
for years 2 and 3, 100% of students responded yes and
for year four, 68% of students responded yes. The
participants were then asked if they thought the
changes will impact them personally, now or in the
near future, 28 (66.7%) participants responded yes.
First year students were 50/50 split, where 100% of
second year, 64% of third years 63% of fourth year
said yes (Table 3). 
The key themes identified included; concerns raised
by participants at all stages, that students qualifying
as an IP will have better employment prospects and
this could be detrimental to current students. Several
students also felt that they may be pushed into
becoming an IP, in order to keep up with the changes.
A few students stated it will affect them due to the
changes in the pre-registration year. Another theme
was that students felt confused or unsure about what
the changes will bring e.g. additional placements and
additional pressures. A final  theme was from earlier
year students who noted that  they were intending to
become IPs anyway. 
Table 3: Qualitative responses when asked if the changes would affect them personally.
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The final question was left open for students to note
any other concerns or questions they wanted to raise;
four students gave a response, three of those were first
year students, one was a fourth year (Table 4). The
main point is that they feel there is a lack of
information available to them about how these





“Many pharmacists simply do not require an IP service. If you are working in sterile
services or on a generic hospital ward, there are many doctors to undertake the
prescribing. So you will be attending university for another year, with more debt, for
a qualification you can’t use. The increase of years may push potential pharmacy
students into medicine due to the closing of the study gap”
“Reducing the number of fee if they are adding an extra year”
“Financially, regarding funding for the course, SFE will have to be flexible and
accommodate the additional year of funding, alternatively an NHS or other body
bursary for fees etc must be arranged. As with everything, pharmacy too is evolving.
The old/traditional community Pharmacy model isn't working. There are a huge
shortage of health care professionals e.g., doctors, and services are being inundated
with high volume of visitors. They are unable to cope, a pharmacist with the integrated
clinical skills development within their degree will help address this issue, as they can
perform preliminary triage, take medical histories, order necessary tests, interpret said
tests, and prescribe medication or refer to appropriate primary care service or
alternative service depending on the acuity of the patients presenting symptoms”
“More information is required about the foundation year such as what will
happen to the pre reg positions, how will IP will be implemented, is this a full
time foundation year course so we will studying or will it be split into working as
pre reg and as a student for the foundation year. Pay needs to be discussed too”







“Those after me qualify as prescribers and are better
placed in the job market”
“Not sure we don’t have enough information about
what exactly is happening with this”
“I think it will oversaturate the prescribing roles unless
new ones are created This may bring down the pay rate”
“It will make a bit harder for us because I cannot
prescribe independently therefore, we might lose some
opportunities”
“Students in lower years will have an advantage of
obtaining the IP before current 4th years”
“these changes will allow a faster pace of change in the
pharmacy sector no matter what stage you're at”
“I feel that future students will be in more demand as
pharmacist, as they can prescribe”
“Even though I was already planning to become a
prescriber myself, this will add the pressure to do it
sooner as I will have more competition when applying
for jobs as these younger pharmacists may have more
qualifications than me”
“Changes are proposed to take place starting













“I believe these changes will
take place gradually”
“I don’t think it would”
“I don't think it will affect
registered pharmacists in 
any way”
“I don't think it will impact 
me personally as I am in 4th
year and I will be carrying out
































relief by NHS /HEE
should be in place
Confusion about
financial implications
and structure of the
foundation / IP
integrated year
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Discussion  
The majority of students who completed the survey
were fourth year students. This could be because that
group had a greater interest in the topic. Most students
in third and fourth years of the MPharm thought that
the changes are going to improve future students’
clinical experience, where students in first and second
year perceived that there is sufficient clinical experience
in the current course. As the changes in Canada and
Ireland gave students more clinical experience, these
UK students believed the changes in the UK curriculum
will achieve similar outcomes. Students in their 3rd and
4th years thought that the pre-registration year changes
will not affect their finance where students from first
and second years felt that the changes will be
detrimental to the financial situation as they were
unsure about how this would be funded or whether it
would classed as unpaid placement. 
Years 3 and 4 students did not think there will be a change
in students’ work-life balance. This could be because they
will finish the course and register before the changes take
place. Students in years 1 and 2 believed that the current
course workload is large and it will be even greater after
the changes, due to more placement and workplace
learning rather than being able to work on assignments
in their own time and having weekends off, which is
perceived to be rarely possible during pre-registration. 
Concerning the impact of the changes on the current
students, all believed that they will be affected
because no current students are likely to be able to
become IPs immediately after they qualify. Fourth year
students agreed that there is a need for pharmacists
to become IPs and adjustments should be made in the
course to facilitate this. 
There was a divide in opinions regarding the benefit of
the changes which could be due to a lack of
information disseminated to students from the GPhC
and Schools of Pharmacy. 
First year students felt it unfair to give the newer
students an IP qualification that might lead to them
having more job opportunities and income advantages.
Fourth year students stated that they believe there
needs to be more clarification around what the
changes actually mean. 
First year students felt it unfair to give the newer
students an IP qualification that might lead to them
having more job opportunities and income
advantages. Fourth year students stated that they
believe there needs to be more clarification around
what the changes actually mean. First year students
raised the issue of funding, and how the extra year at
university would be paid for, one even saying that
Student Finance England would have to accommodate
the extra year, or another government body would
have to fund it. Another student in first year stated that
not all pharmacists’ roles require an IP qualification
and that students will be spending another year at
university with extra fees and debt for a qualification
they may never use. Therefore, despite the fact that all
fourth-year students had heard of these changes and
they clearly have an interest in them, they stated that
there is a deficit in information surrounding the funding
and pay that need to be disclosed by the GPhC. While
some very few universities started the five years
courses, it is very early years and the final years
curriculum, the clinical placement practicality and cost
are not yet put into test. Additionally, the outcome, the
new type of pharmacists graduated from the five year
course, the ability for the institutions to sustain
placements places, the affordability of the course to
students populations, are not yet evaluated.   
Limitations  
The study had some limitations imposed upon it by
the COVID-19 pandemic, where interviews and focus
groups were not permitted. The use of the online
survey limited the number of questions been asked
and the number of participants. The lack of
information accessible to the students regarding the
details of the changes limited how students
responded. Other factors that may have influenced the
students’ opinions is previous work experience within
the profession, as some students may have worked in
pharmacy before, some may already be technicians
and are advancing their career while others may have
never worked in pharmacy before. This could influence
how much they understood about the profession and
the roles of IPs, as well as how much information to
which they may have access. 
Conclusion   
The results from this survey suggest that students
mostly believe that having an IP qualification is
beneficial, although some disagree. Fourth year
students in particular did not believe that there is
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enough clinical experience on the current course and
that it does need adjusting. They also identified a
deficit in information surrounding how these changes
are going to be put into practice, how the course will
change, how will it be funded and what this means for
students and pharmacists alike.  
Recommendations   
• More information is required from the GPhC and
Health Education England (HEE), both to students
and to the universities and training sites. 
• There needs to be more information also available to
pharmacists regarding how this change will affect them
and how the current workforce will be upskilled. 
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